Mon, September 13, 2010
[ Mon, Sep 13th 2010 ] - Market Wire
Il regime quadruplo a monosomministrazione giorna .. 'HIV di Gilead consente il mantenimento di una so
[ Mon, Sep 13th 2010 ] - Market Wire
A New Audio Interview Featuring Frank Mir, Director of Suffer Apparel, is Now at SmallCapVoice.com
[ Mon, Sep 13th 2010 ] - Market Wire
Allos Therapeutics to Present at Upcoming Investor Conferences
[ Mon, Sep 13th 2010 ] - Market Wire
PerkinElmer to Present at UBS Global Life Science Conference
[ Mon, Sep 13th 2010 ] - Market Wire
ARIAD Announces Initiation of Ponatinib (AP24534) .. -Resistant or Intolerant Chronic Myeloid Leukemia
[ Mon, Sep 13th 2010 ] - Market Wire
Pro-Pharmaceuticals Collaborates with Numoda to M .. l Trial to Increase Speed-to-Market for DAVANAT®
[ Mon, Sep 13th 2010 ] - Market Wire
Geron Obtains Exclusive License for Deriving Cart .. Embryonic Stem Cells from University of Edinburgh
[ Mon, Sep 13th 2010 ] - Market Wire
Forest Responds to FDA Complete Response Letter for Roflumilast
[ Mon, Sep 13th 2010 ] - Market Wire
UnitedHealth Group Named to Dow Jones Sustainabil .. erica and World Indices for 12th Consecutive Year
[ Mon, Sep 13th 2010 ] - Market Wire
XenoPort Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity
[ Mon, Sep 13th 2010 ] - Market Wire
LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics
[ Mon, Sep 13th 2010 ] - Market Wire
Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference
Sun, September 12, 2010
[ Sun, Sep 12th 2010 ] - Market Wire
Santarus Adds Two Novel Biologic Drug Candidates to Pipeline
Fri, September 10, 2010
[ Fri, Sep 10th 2010 ] - Market Wire
NexMed, Inc. Announces Results of Special Meeting .. ers, Including Name Change to Apricus Biosciences
[ Fri, Sep 10th 2010 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. Discuss Top-line Data from Lintuzumab (SGN-33) Ph
[ Fri, Sep 10th 2010 ] - Market Wire
Advanced Cell Technology to Present at the 12th A .. ual Rodman & Renshaw Global Investment Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Orthovita to Present at the UBS Global Life Sciences Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Medtronic Releases 2010 Corporate Citizenship Report
[ Fri, Sep 10th 2010 ] - Market Wire
Teva to Present at the Morgan Stanley Global Healthcare Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Cubist Pharmaceuticalsa? Antibiotic Programs Featured in 47 Presentations at 50th ICAAC
[ Fri, Sep 10th 2010 ] - Market Wire
ArQule, Inc. to Present at Stifel Nicolaus and UBS Conferences
[ Fri, Sep 10th 2010 ] - Market Wire
PerkinElmer to Present at Stifel Nicolaus Healthcare Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Orthofix International to Participate inStifel Nicolaus 2010 Healthcare Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Pro-Pharmaceuticalsa? Presentation at Rodman and .. l Global Investment Conference to Be Webcast Live
[ Fri, Sep 10th 2010 ] - Market Wire
Bioniche Reports Fiscal 2010 Year-End Results
Thu, September 9, 2010
[ Thu, Sep 09th 2010 ] - Market Wire
Amedisys to Present at Two Upcoming Conferences
[ Thu, Sep 09th 2010 ] - Market Wire
Tenet Management to Speak at the Morgan Stanley Global Healthcare Conference on September 14, 2010
[ Thu, Sep 09th 2010 ] - Market Wire
Cohen Milstein Sellers & Toll PLLC Announces Class Action Lawsuit against Almost Family, Inc.
[ Thu, Sep 09th 2010 ] - Market Wire
Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences
[ Thu, Sep 09th 2010 ] - Market Wire
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
[ Thu, Sep 09th 2010 ] - Market Wire
Elan Statement Regarding Shareholder Call
[ Thu, Sep 09th 2010 ] - Market Wire
Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. an &; Renshaw Annual Global Investment Conference
[ Thu, Sep 09th 2010 ] - Market Wire
AngioDynamics to Participate At Upcoming Investor Conferences
[ Thu, Sep 09th 2010 ] - Market Wire
CombinatoRx Changes Company Name to Zalicus Inc.
[ Thu, Sep 09th 2010 ] - Market Wire
Salix Pharmaceuticals to Present at Stifel Nicolaus Conference
[ Thu, Sep 09th 2010 ] - Market Wire
Schiff Nutrition International, Inc. to Present a .. ing's 8th Best Ideas Conference on September 16th
[ Thu, Sep 09th 2010 ] - Market Wire
Schiff Nutrition International, Inc. Announces Timing of Fiscal 2011 First Quarter Results
Wed, September 8, 2010
[ Wed, Sep 08th 2010 ] - Market Wire
YM BioSciences announces positive results from CY .. se I study published in British Journal of Cancer
[ Wed, Sep 08th 2010 ] - Market Wire
Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. on Lawsuit Against SciClone Pharmaceuticals, Inc.
[ Wed, Sep 08th 2010 ] - Market Wire
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
Kindred Healthcare to Participate in the Stifel Nicolaus 2010 Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results
[ Wed, Sep 08th 2010 ] - Market Wire
FDA Advisory Committee Recommends Approval of For .. e Fosamil for the Treatment of Community Acquired
[ Wed, Sep 08th 2010 ] - Market Wire
AGA Medical to Present at the Baird 2010 Health Care Conference
[ Wed, Sep 08th 2010 ] - Market Wire
PPD Establishes Network of Sites for Conducting Phase I Trials in Patients
[ Wed, Sep 08th 2010 ] - Market Wire
Health Management Associates, Inc. to Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
65% of People Whose Prior Treatment for Hepatitis .. SVR (Viral Cure) with Telaprevir-Based Therapy in
[ Wed, Sep 08th 2010 ] - Market Wire
Resurrectiona" Showcased to NYC at the Attica 2 Year Anniversary Party
Tue, September 7, 2010
[ Tue, Sep 07th 2010 ] - Market Wire
Array BioPharma to Present at the Rodman & Rensha .. nce and the Stifel Nicolaus Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
La Jolla Pharmaceutical Company Provides Update o .. ch for Clinical Products to In-License or Acquire
[ Tue, Sep 07th 2010 ] - Market Wire
Orthofix International to Participate in Morgan Stanley Unplugged Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Health Net Federal Services Meets Target Enrollme .. Chronic Obstructive Pulmonary Disease Management
[ Tue, Sep 07th 2010 ] - Market Wire
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
[ Tue, Sep 07th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Commercial Availability of Silenor
[ Tue, Sep 07th 2010 ] - Market Wire
Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Response Genetics, Inc. to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Rosetta Genomics to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
[ Tue, Sep 07th 2010 ] - Market Wire
BioDelivery Sciences Adds New Executive to Lead Business and Strategic Development
[ Tue, Sep 07th 2010 ] - Market Wire
SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference on September 13th
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ] - Market Wire
Herbert A. Fritsche, Ph.D., anteriormente profeso .. on Cancer Center, se incorpora a Health Discovery
[ Sat, Sep 04th 2010 ] - Market Wire
Transdel Pharmaceuticals
[ Sat, Sep 04th 2010 ] - Market Wire
Curis to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Sat, Sep 04th 2010 ] - Market Wire
Wright Medical Group, Inc. to Participate in Upcoming September 2010 Healthcare Conferences
[ Sat, Sep 04th 2010 ] - Market Wire
Aetna Reminds Members Affected by Hurricane Earl Where to Call for Help
[ Sat, Sep 04th 2010 ] - Market Wire
Herbert A. Fritsche, Ph.D., ehemaliger Professor .. nderson Cancer Center tritt Health Discovery Corp
[ Sat, Sep 04th 2010 ] - Market Wire
UnitedHealth Group to Support Members Affected by Hurricane Earl
Fri, September 3, 2010
[ Fri, Sep 03rd 2010 ] - Market Wire
Herbert A. Fritsche, Ph.D., cientista e antigo pr .. o do Anderson Cancer Center, junta-se a Health Di
[ Fri, Sep 03rd 2010 ] - Market Wire
Gilead Sciences presenta alla?Agenzia Europea per .. torizzazione per la?immissione in commercio delle
[ Fri, Sep 03rd 2010 ] - Market Wire
Life Technologies to Present at the UBS Global Life Sciences Conference
[ Fri, Sep 03rd 2010 ] - Market Wire
KCI?????LifeCella" ???Novadaq Technologies????????????SPY®????????????
[ Fri, Sep 03rd 2010 ] - Market Wire
/C O R R E C T I O N - Mindray Medical International Limited /
[ Fri, Sep 03rd 2010 ] - Market Wire
MDS to Release Third Quarter 2010 Financial Results
[ Fri, Sep 03rd 2010 ] - Market Wire
Tibotec Pharmaceuticals Seeks European Marketing .. r Investigational Once-Daily HIV Treatment TMC278
[ Fri, Sep 03rd 2010 ] - Market Wire
Medisafe 1 Technologies Clarifies the PR Issued o .. ividend, as a Forward Split of 5-1 in the Form of
[ Fri, Sep 03rd 2010 ] - Market Wire
Gilead Sciences Submits European Marketing Applic .. blet Regimen of Truvada® and TMC278 for the Trea
[ Fri, Sep 03rd 2010 ] - Market Wire
Alcon Launches AcrySof® IQ ReSTOR® Toric Intraocular Lens Outside the United States
[ Fri, Sep 03rd 2010 ] - Market Wire
Gilead Sciences dient aanvraag in voor Europese m .. van ©©n tablet per dag van Truvada en TMC278 t
Thu, September 2, 2010
[ Thu, Sep 02nd 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.
[ Thu, Sep 02nd 2010 ] - Market Wire
BRINAVESSa" (vernakalant) per infusione approvato .. conversione rapida della fibrillazione atriale di
[ Thu, Sep 02nd 2010 ] - Market Wire
BioDelivery Sciences Announces Positive Meeting w .. eamlined ONSOLIS REMS with Broadened Distribution
[ Thu, Sep 02nd 2010 ] - Market Wire
KCIa?s LifeCell Corporation en Novadaq Technologi .. verkoop- en marketingovereenkomst voor exclusieve
[ Thu, Sep 02nd 2010 ] - Market Wire
Cardiome Achieves $30 Million Milestone
[ Thu, Sep 02nd 2010 ] - Market Wire
Rosetta Genomics to Host Second Quarter 2010 Conference Call on Wednesday, September 8, 2010
[ Thu, Sep 02nd 2010 ] - Market Wire
MedPro Safety Products Completes Royalty Monetization Transaction
[ Thu, Sep 02nd 2010 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September
[ Thu, Sep 02nd 2010 ] - Market Wire
Gilead geeft update over aandelenterugkoop van 5 miljard dollar
[ Thu, Sep 02nd 2010 ] - Market Wire
Transdel Pharmaceuticals Presents Phase 3 Study D .. sdel® at World Pain Congress in Montreal, Canada
[ Thu, Sep 02nd 2010 ] - Market Wire
La divisione di KCI LifeCella" Corporation e Nova .. contratto di vendita e marketing per la distribu
Wed, September 1, 2010
[ Wed, Sep 01st 2010 ] - Market Wire
Health Net Strives to Exceed $75,000 Goal Through Annual Golf Classic Despite Hard Economic Times
[ Wed, Sep 01st 2010 ] - Market Wire
Navigant Capital Advisors, LLC Serves as Financia .. Health Systems, Inc. in Its $156.8 Million Sale t
[ Wed, Sep 01st 2010 ] - Market Wire
Amerigroup Launches 24/7 Nurse Pilot Program: A First for Tennessee
[ Wed, Sep 01st 2010 ] - Market Wire
Amerigroup Launches 24/7 Nurse Pilot Program: A First for Maryland
[ Wed, Sep 01st 2010 ] - Market Wire
Inhibitex Successfully Completes Phase 1a Trial of INX-189
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien Announces Investor Meeting Agenda
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien annuncia il programma della riunione degli investitori
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien gibt Tagesordnung seiner Investorenversammlung bekannt
[ Wed, Sep 01st 2010 ] - Market Wire
Archimedes Pharma Receives European Marketing Aut .. (R) for the Treatment of Breakthrough Cancer Pain
[ Wed, Sep 01st 2010 ] - Market Wire
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
[ Wed, Sep 01st 2010 ] - Market Wire
Emergent BioSolutions Awarded NIAID Contract That .. to Over $58 Million for Advanced Development of T
Tue, August 31, 2010
[ Tue, Aug 31st 2010 ] - Market Wire
New 2010 ESC Guidelines for Percutaneous Coronary .. rtance of FFR in Treatment of Coronary Artery Dis
[ Tue, Aug 31st 2010 ] - Market Wire
Allergan, Inc. Receives FDA Approval for LUMIGANÂ .. Indicated for the Reduction of Elevated Intraocul
[ Tue, Aug 31st 2010 ] - Market Wire
Teleflex to Present at the Stifel Nicolaus 2010 Healthcare Conference
[ Tue, Aug 31st 2010 ] - Market Wire
Quidel Announces FDA Clearance of Its RapidVue® hCG Pregnancy Lateral Flow Diagnostic Test
[ Tue, Aug 31st 2010 ] - Market Wire
Tenet Announces Completion of Cash Tender Offer for 7.375% Senior Notes due 2013
[ Tue, Aug 31st 2010 ] - Market Wire
Humana Awarded Contracts for Puerto Rico Medicaid Program
[ Tue, Aug 31st 2010 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation on Behalf of Shareholders of Genzyme Corporation
[ Tue, Aug 31st 2010 ] - Market Wire
Progenics Pharmaceuticals to Present Preclinical .. nal Antibodies Against C. difficile at 2010 ICAAC
[ Tue, Aug 31st 2010 ] - Market Wire
American CareSource Holdings Adds Benefit Administrative Systems to Client Portfolio
[ Tue, Aug 31st 2010 ] - Market Wire
Orthofix International Establishes New $300 Million Credit Facility
[ Tue, Aug 31st 2010 ] - Market Wire
Affymax® Announces Upcoming Webcasts and Conference Participation
Mon, August 30, 2010
[ Mon, Aug 30th 2010 ] - Market Wire
Elan Corporation plc Announces Commencement of As .. to $186,000,000 of 8 7/8% Senior Fixed Rate Note
[ Mon, Aug 30th 2010 ] - Market Wire
Teleflex to Present at the Morgan Stanley Global Healthcare Conference
[ Mon, Aug 30th 2010 ] - Market Wire
Pre and Post-Operative Use of Caldolor® (Ibuprof .. duces Pain and Opioid Use in Newly Published Stud
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien voltooit verkoop van productlijn voor slaaptherapie
[ Mon, Aug 30th 2010 ] - Market Wire
Biomagnetics Announces LOI to Acquire Lanzhou New .. TD Fourth Chinese Asset Targeted at $1.50 BMGP Sh
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien Completes Sale of Sleep Therapy Product Line
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien perfeziona la vendita della linea di prodotti per la terapia del sonno
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien cl'ture la vente de sa ligne de produits de th©rapie du sommeil
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien schliet Verkauf der Produktlinie fr Schlaftherapien ab
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien Completes Sale of Specialty Chemicals Business
[ Mon, Aug 30th 2010 ] - Market Wire
PURATEIN(R) AND SUPERTEIN(TM) GRAS NOTIFIED - U.S .. ISSUES NO OBJECTION LETTER ON GRAS STATUS OF PUR
Sun, August 29, 2010
[ Sun, Aug 29th 2010 ] - Market Wire
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Fri, August 27, 2010
[ Fri, Aug 27th 2010 ] - Market Wire
Aetna Completes $750 Million, 10-Year Bond Offering
[ Fri, Aug 27th 2010 ] - Market Wire
Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.
[ Fri, Aug 27th 2010 ] - Market Wire
Zynex Announces New ChiefFinancial Officer
[ Fri, Aug 27th 2010 ] - Market Wire
Experienced Financial Executive, Peter Donato, Joins Hythiam as CFO
[ Fri, Aug 27th 2010 ] - Market Wire
?????????????????????
[ Fri, Aug 27th 2010 ] - Market Wire
HealthSpring, Inc. to Acquire Bravo Health, Inc.
[ Fri, Aug 27th 2010 ] - Market Wire
Genentech Receives Refuse to File Letter from FDA for T-DM1
Thu, August 26, 2010
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis conclui compra de participao majoritria da Nestl© na Alcon
[ Thu, Aug 26th 2010 ] - Market Wire
RehabCare to Present at the Morgan Stanley Global Healthcare Conference
[ Thu, Aug 26th 2010 ] - Market Wire
Spectral Molecular Imaging, Inc. Announces Accele .. its Early Melanoma Detection Product SkinSpecta"
[ Thu, Aug 26th 2010 ] - Market Wire
Health Net, Inc. Mourns the Death of Thomas T. Farley, a Member of Its Board of Directors
[ Thu, Aug 26th 2010 ] - Market Wire
American HomePatient Announces Five Business Day .. lf-Tender Offer and Modification of 90% Condition
[ Thu, Aug 26th 2010 ] - Market Wire
Medtronic reoit de Sant© Canada la?homologation .. ?ablation de la fibrillation auriculaire par radi
[ Thu, Aug 26th 2010 ] - Market Wire
Medtronic Receives Health Canada Approval for the .. ofrequency Ablation Tools for Atrial Fibrillation
[ Thu, Aug 26th 2010 ] - Market Wire
International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban
[ Thu, Aug 26th 2010 ] - Market Wire
Celgene Corporation Announces Appointment of Jacq .. Senior Vice President and Chief Financial Officer
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis voltooit aankoop meerderheidsbelang Alcon van Nestl©
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis completa acquisto da Nestl© di interesse di maggioranza su Alcon
Wed, August 25, 2010
[ Wed, Aug 25th 2010 ] - Market Wire
Novartis Completes Purchase from Nestl© of Majority Interest in Alcon
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic, Boston Scientific, St. Jude Medical, Haemonetics and Cyberonics
[ Wed, Aug 25th 2010 ] - Market Wire
The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development
[ Wed, Aug 25th 2010 ] - Market Wire
Impax Pharmaceuticals Completes Enrollment in ADV .. Phase III Trial of IPX066 in Parkinsona?s Disease
[ Wed, Aug 25th 2010 ] - Market Wire
Health Net Wins Award in 2010 National Mature Media Awards Program
[ Wed, Aug 25th 2010 ] - Market Wire
HEALTH NET GANA PREMIO EN EL PROGRAMA NATIONAL MATURE MEDIA AWARDS 2010
[ Wed, Aug 25th 2010 ] - Market Wire
Northstar Healthcare Calls Special Meeting of Shareholders and Amends Private Placement Agreement
[ Wed, Aug 25th 2010 ] - Market Wire
Exclusive Partnership between Healthways, MedNetw .. of Social Networks to Improve Health, Well-Being
[ Wed, Aug 25th 2010 ] - Market Wire
Celgene Expects to Receive a Paragraph IV Notification of an ANDA Filing for REVLIMID®
[ Wed, Aug 25th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Silenor® Co-Promotion Agreement with Procter & Gamble
[ Wed, Aug 25th 2010 ] - Market Wire
Inspire Announces Amendment to Ophthalmic Collaboration
Tue, August 24, 2010
[ Tue, Aug 24th 2010 ] - Market Wire
Le systme PureGrafta" de Cytori reoit l'approbati .. urop©enne pour les proc©dures de lipo-injection
[ Tue, Aug 24th 2010 ] - Market Wire
Donn©es pr©liminaires venant appuyer le test da .. s anti-JCV publi©es dans les Annals of Neurology
[ Tue, Aug 24th 2010 ] - Market Wire
Bernstein Liebhard LLP Announces Class Action Has .. led on Behalf of Investors in Almost Family, Inc.
[ Tue, Aug 24th 2010 ] - Market Wire
BioAlliance Pharma Announces the Launch of Oravig .. s Commercial Partner, Strativa/Par Pharmaceutical
[ Tue, Aug 24th 2010 ] - Market Wire
Dati preliminari a sostegno di un'analisi investi .. il virus JC, pubblicati negli Annali di neurolog
[ Tue, Aug 24th 2010 ] - Market Wire
Vorlufige Daten untersttzen experimentellen JCV-A .. heinen in der Fachzeitschrift Annals of Neurology
[ Tue, Aug 24th 2010 ] - Market Wire
Preliminary Data in Support of Investigational An .. tibody Assay Published in the Annals of Neurology
[ Tue, Aug 24th 2010 ] - Market Wire
Kindred Healthcare Signs Definitive Agreements to .. hree Nursing and Rehabilitation Centers in Growin
[ Tue, Aug 24th 2010 ] - Market Wire
Isotechnika Pharma and 3SBio Announce Strategic P .. to Develop and Commercialize Voclosporin in China
[ Tue, Aug 24th 2010 ] - Market Wire
Pro-Pharmaceuticalsa? Executives to Present Corpo .. Update at Three Investor Conferences in September
[ Tue, Aug 24th 2010 ] - Market Wire
Alnylam Scientists Present New Data on RNAi Thera .. ican Chemical Society (ACS) 2010 National Meeting
Mon, August 23, 2010
[ Mon, Aug 23rd 2010 ] - Market Wire
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIAa"
[ Mon, Aug 23rd 2010 ] - Market Wire
DIAGNOCURE RETAINS THE SERVICES OF JMP SECURITIES LLC
[ Mon, Aug 23rd 2010 ] - Market Wire
Topline Results From Phase 3 Trial of Sunitinib W .. ib in Advanced Non-Small Cell Lung Cancer (NSCLC)
[ Mon, Aug 23rd 2010 ] - Market Wire
Law Office of Jonathan M. Stein, P.L. Investigate .. y Duty by the Board of Prospect Medical Holdings,
[ Mon, Aug 23rd 2010 ] - Market Wire
No-Cost Electronic Prescribing Service Now Available to Kentucky Physicians
[ Mon, Aug 23rd 2010 ] - Market Wire
MannKind Corporation Providing AFREZZAa" to Juven .. search Foundation for Artificial Pancreas Project
[ Mon, Aug 23rd 2010 ] - Market Wire
NexMed Receives Additional Patent Coverage for Israel
[ Mon, Aug 23rd 2010 ] - Market Wire
InSite Vision Commences Phase 1/2 Clinical Study .. SV-303 for Post-Surgical Ocular Pain and Swelling
[ Mon, Aug 23rd 2010 ] - Market Wire
Alnylam and Collaborators Publish New Pre-clinica .. herapeutic Silencing of Parkinsona?s Disease Gene
[ Mon, Aug 23rd 2010 ] - Market Wire
Alexion Receives FDA Approval of Rhode Island Manufacturing Facility for Soliris® Supply
[ Mon, Aug 23rd 2010 ] - Market Wire
AGM Resolution Filed for Entry in the Commercial Register
Fri, August 20, 2010
[ Fri, Aug 20th 2010 ] - Market Wire
Angeion to Announce 2010 Third-Quarter Results on Wednesday, August 25
[ Fri, Aug 20th 2010 ] - Market Wire
Cubist Pharmaceuticals Named One of Fortunea?s a100 Fastest-Growing Companiesa
[ Fri, Aug 20th 2010 ] - Market Wire
Aetna Reminds Members in Tennessee Affected by Flooding Where to Call for Help
[ Fri, Aug 20th 2010 ] - Market Wire
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN®, 10 mg/80 mg
[ Fri, Aug 20th 2010 ] - Market Wire
REVLIMID in Japan goedgekeurd voor behandeling 5q myelodysplastisch deletie syndroom
[ Fri, Aug 20th 2010 ] - Market Wire
Aprobacin de REVLIMID® para el tratamiento del sndrome mielodisplstico con delecin 5q en Japn
[ Fri, Aug 20th 2010 ] - Market Wire
Gilead Sciences anuncia notificacin de presentaci .. d abreviada de nuevo frmaco (ANDA) para Hepsera®
[ Fri, Aug 20th 2010 ] - Market Wire
Gilead Sciences gibt Benachrichtigung ber ANDA-Einreichung fr Hepsera® bekannt
[ Fri, Aug 20th 2010 ] - Market Wire
REVLIMID® zur Behandlung von myelodysplastischen Syndromen mit 5q-Deletion in Japan zugelassen
[ Fri, Aug 20th 2010 ] - Market Wire
Gilead Sciences meldt ontvangst ANDA-aanvraag voor Hepsera
[ Fri, Aug 20th 2010 ] - Market Wire
Gilead Sciences annuncia di aver ricevuto una not .. anda abbreviata per l'approvazione di un nuovo fa
Thu, August 19, 2010
[ Thu, Aug 19th 2010 ] - Market Wire
REVLIMID® Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
[ Thu, Aug 19th 2010 ] - Market Wire
Urologix Announces Election of Patrick D. Spangler as Director
[ Thu, Aug 19th 2010 ] - Market Wire
Human Genome Sciences und GlaxoSmithKline melden .. r FDA fr BENLYSTA® (Belimumab) als potenzielle B
[ Thu, Aug 19th 2010 ] - Market Wire
Human Genome Sciences en GlaxoSmithKline melden t .. door FDA voor BENLYSTA® (belimumab) als potentil
[ Thu, Aug 19th 2010 ] - Market Wire
Human Genome Sciences e GlaxoSmithKline annuncian .. ioritaria da parte della FDA per BENLYSTA® (beli
[ Thu, Aug 19th 2010 ] - Market Wire
Positron Announces Strategic Alliance with Covidien; to Develop Innovative Distribution Model
[ Thu, Aug 19th 2010 ] - Market Wire
International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs into Cytovisa"
[ Thu, Aug 19th 2010 ] - Market Wire
Human Genome Sciences and GlaxoSmithKline Announc .. ion for BENLYSTA® (belimumab) as a Potential Tre
[ Thu, Aug 19th 2010 ] - Market Wire
MannKind Announces Pricing of $100 Million Senior Convertible Notes
[ Thu, Aug 19th 2010 ] - Market Wire
MannKind Announces Entry into Stock Lending Agreement
[ Thu, Aug 19th 2010 ] - Market Wire
Additional Phase III clinical trial with Urocidin(TM) expected to commence in 2010
Wed, August 18, 2010
[ Wed, Aug 18th 2010 ] - Market Wire
Northstar Healthcare Announces the TSX has Declined to Approve Financial Hardship Application
[ Wed, Aug 18th 2010 ] - Market Wire
Angeion and BlueLine Partners Enter Into Agreement
[ Wed, Aug 18th 2010 ] - Market Wire
Celgene, Abraxis BioScience, Johnson & Johnson, SuperGen and Biogen Idec

ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September


//health-fitness.news-articles.net/content/2010/ .. -multiple-investor-conferences-in-september.html
Published in Health and Fitness on Thursday, September 2nd 2010 at 6:36 GMT by Market Wire   Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--[ ImmunoGen, Inc ]. (Nasdaq: IMGN), a biotechnology company that develops antibody-based targeted anticancer products, today announced that Company management will present at multiple investor conferences this month. The live webcast of each presentation can be accessed through the aInvestor Informationa section of the Companya™s website, [ www.immunogen.com ]; a replay of each presentation will be available for one week.

  • 2010 Morgan Stanley Global Healthcare Unplugged Conference
    8:00 a.m.EDT on September 13, 2010in New York, NY
    Presenter: Daniel Junius, President and CEO
  • Stifel Nicolaus 2010 Healthcare Conference
    11:30 a.m.EDT on September 15, 2010in Boston, MA
    Presenter: Gregory Perry, Senior Vice President and CFO
  • Bank of America Merrill Lynch Global Healthcare Conference 2010
    1:00 p.m.BST (8:00 a.m. EDT) on September 16, 2010in London,England
    Presenter: Daniel Junius, President and CEO
  • UBS Global Life Sciences Conference
    12:00 p.m.EDT on September 20, 2010inNew York, NY
    Presenter: Gregory Perry, Senior Vice President and CFO

About ImmunoGen, Inc.

ImmunoGen, Inc. develops targeted anticancer therapeutics using its expertise in cancer biology, monoclonal antibodies and the creation and attachment of potent cancer cell-killing agents. The Companya™s Targeted Antibody Payload (TAP) technology uses engineered antibodies to deliver one of ImmunoGena™s proprietary cancer-cell killing agents specifically to tumor targets. Product candidates are in development through the Companya™s own product programs and through ImmunoGena™s collaborations with Amgen, Bayer Schering Pharma, Biogen Idec, Biotest, Genentech (a member of the Roche Group), and sanofi-aventis. The most advanced compound using ImmunoGena™s TAP technology, T-DM1, is in Phase III testing through the Companya™s collaboration with Genentech.


Publication Contributing Sources